Semler Scientific price target lowered to $86 from $101 at Benchmark

Benchmark lowered the firm’s price target on Semler Scientific (SMLR) to $86 from $101 and keeps a Buy rating on the shares after Semler agreed to be acquired by Strive (ASST) in an all-stock deal. While the market is sorting out the longer-term implications of the transaction, it appears to the firm that Semler shares “represent an opportunity right now” and that this deal seems to have “rung the opening bell for consolidation in the corporate bitcoin (BTC-USD) treasury space,” the analyst tells investors.